Brief: Hemcheck Signs Subscription Agreement With Tartu University Hospital In Estonia
Oct 21 (Reuters) - Hemcheck Sweden AB HEMC.ST :
* SAID ON TUESDAY IT HAS SIGNED SUBSCRIPTION AGREEMENT WITH
TARTU
UNIVERSITY HOSPITAL IN ESTONIA
* REVENUES FROM THE CONTRACT ARE AT EUR 18,000 IN THE
UPCOMING
YEAR FOR HEMCHECK
Source text for Eikon: urn:newsml:reuters.com:*:nWkrB0vLB
Further company coverage: HEMC.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10))
Recent news on Bio Vitos Pharma AB
See all newsAdvisory: Alerts on Bio Vitos Pharma withdrawn
Brief: Bio Vitos Pharma Q4 Operating Revenue Falls To SEK 0.3 Mln
Brief: Bio Vitos Reaches Settlement With Norvolt AS, Norvolt Capital AS
Brief: Bio Vitos Pharma Appoints Sven Rohmann As Acting CEO
Brief: Bio Vitos Pharma Q3 Loss After Financial Items SEK 3.0 Mln